Plasminogen

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (09:07, 24 November 2019) (edit) (undo)
 
(4 intermediate revisions not shown.)
Line 9: Line 9:
== Structural highlights ==
== Structural highlights ==
-
<scene name='46/465445/Cv/2'>PLN contains 7 domains</scene> which are: N-terminal, C-terminal serine protease catalytic domain and 5 kringle domains of ca. 80 residues. The <scene name='46/465445/Cv/3'>kringle domain folds into a large loop containing 3 disulfide bonds</scene>, ''e.g.'' <scene name='46/465445/Cv/4'>Kringle 4</scene>. The kringle domain is important in protein-protein interaction with blood coagulation factors.<ref>PMID:22832192</ref>.
+
<scene name='46/465445/Cv/11'>PLN contains 7 domains</scene> which are: N-terminal, C-terminal serine protease catalytic domain and 5 kringle domains of ca. 80 residues. The <scene name='46/465445/Cv/3'>kringle domain folds into a large loop containing 3 disulfide bonds</scene>, ''e.g.'' <scene name='46/465445/Cv/4'>Kringle 4</scene>. The kringle domain is important in protein-protein interaction with blood coagulation factors.<ref>PMID:22832192</ref>.
-
*<scene name='46/465445/Cv/6'>K ion coordination site</scene>. Water molecules shown as red spheres.
+
*<scene name='46/465445/Cv/12'>K ion coordination site</scene>. Water molecules are shown as red spheres.
-
*<scene name='46/465445/Cv/7'>Cl ion coordination site I</scene>.
+
*<scene name='46/465445/Cv/13'>Cl ion coordination site I</scene>.
-
*<scene name='46/465445/Cv/8'>Cl ion coordination site II</scene>.
+
*<scene name='46/465445/Cv/14'>Cl ion coordination site II</scene>.
-
*<scene name='46/465445/Cv/9'>Cl ion coordination site III</scene>.
+
*<scene name='46/465445/Cv/15'>Cl ion coordination site III</scene>.
-
*<scene name='46/465445/Cv/10'>Cl ion coordination site IV</scene>.
+
*<scene name='46/465445/Cv/16'>Cl ion coordination site IV</scene>.
-
</StructureSection>
+
 
== 3D Structures of plasminogen ==
== 3D Structures of plasminogen ==
 +
[[Plasminogen 3D structures]]
-
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
+
</StructureSection>
-
{{#tree:id=OrganizedByTopic|openlevels=0|
+
-
 
+
-
*Plasminogen
+
-
 
+
-
**[[4dur]], [[4duu]], [[4a5t]] – hPLG 2 - human
+
-
 
+
-
*Plasminogen kringle 1
+
-
 
+
-
**[[1pkr]] - hPLG kringle 1 <BR />
+
-
**[[1cea]] - hPLG kringle 1 + e-aminocaprioic acid<BR />
+
-
**[[1hpj]], [[1hpk]] - hPLG kringle 1 + 6-aminohexanoic acid - NMR<BR />
+
-
**[[1ceb]] - hPLG kringle 1 + AMCHA<br />
+
-
**[[4cik]] - hPLG kringle 1 + inhibitor<br />
+
-
 
+
-
*Plasminogen kringle 2
+
-
 
+
-
**[[1b2i]] - hPLG kringle 2 (mutant) – NMR<BR />
+
-
**[[1i5k]] - hPLG kringle 2 (mutant) + M2 protein peptide<BR />
+
-
**[[2kj4]] – hPLG kringle 2 + M2 protein peptide – NMR<BR />
+
-
 
+
-
*Plasminogen kringle 3
+
-
 
+
-
**[[2l0s]] - hPLG kringle 3 – NMR<BR />
+
-
 
+
-
*Plasminogen kringle 4
+
-
 
+
-
**[[1pk4]], [[1pmk]], [[1pml]], [[1krn]] – hPLG kringle 4<BR />
+
-
**[[2pk4]] - hPLG kringle 4 + e-aminocaprioic acid
+
-
 
+
-
*Plasminogen kringle 5
+
-
 
+
-
**[[5hpg]] - hPLG kringle 5<BR />
+
-
**[[2knf]] - hPLG kringle 5 – NMR<BR />
+
-
 
+
-
*Plasminogen catalytic domain
+
-
 
+
-
**[[1qrz]], [[1ddj]], [[1rjx]] – hPLG catalytic domain (mutant)<br />
+
-
**[[1l4d]], [[1l4z]] - hPLG catalytic domain (mutant) + streptokinase α domain
+
-
 
+
-
*Plasmin
+
-
 
+
-
**[[1bml]] – hPLN catalytic domain + streptokinase<BR />
+
-
**[[1bui]] – hPLN light chain + staphylokinase
+
-
 
+
-
*Microplasmin
+
-
**[[5ugd]], [[5ugg]] – hPLN <br />
 
-
**[[3uir]] – hPLN + textilinin-1<br />
 
-
}}
 
== References ==
== References ==
<references/>
<references/>
[[Category:Topic Page]]
[[Category:Topic Page]]

Current revision

Human glycosylated plasminogen complex with acetate, bicarbonate, K+ (purple) and Cl- (green) ions (PDB entry 4dur)

Drag the structure with the mouse to rotate

References

  1. Goldenberg DT, Giblin FJ, Cheng M, Chintala SK, Trese MT, Drenser KA, Ruby AJ. Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes. Retina. 2011 Feb;31(2):393-400. doi: 10.1097/IAE.0b013e3181e586b2. PMID:21099453 doi:http://dx.doi.org/10.1097/IAE.0b013e3181e586b2
  2. Mehta R, Shapiro AD. Plasminogen deficiency. Haemophilia. 2008 Nov;14(6):1261-8. doi: 10.1111/j.1365-2516.2008.01825.x. PMID:19141167 doi:http://dx.doi.org/10.1111/j.1365-2516.2008.01825.x
  3. Law RH, Caradoc-Davies T, Cowieson N, Horvath AJ, Quek AJ, Encarnacao JA, Steer D, Cowan A, Zhang Q, Lu BG, Pike RN, Smith AI, Coughlin PB, Whisstock JC. The X-ray crystal structure of full-length human plasminogen. Cell Rep. 2012 Mar 29;1(3):185-90. doi: 10.1016/j.celrep.2012.02.012. Epub 2012, Mar 8. PMID:22832192 doi:10.1016/j.celrep.2012.02.012

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman

Personal tools